
Axonics Investor Relations Material
Latest events

Q3 2023
Axonics

Q3 2024
7 Nov, 2024

Q2 2024
1 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Axonics Inc
Access all reports
Axonics, Inc. is a medical technology company specializing in implantable devices for the treatment of bladder and bowel dysfunction. The company develops and markets sacral neuromodulation systems designed to provide long-term relief for patients with conditions such as overactive bladder, urinary retention, and fecal incontinence. Axonics focuses on innovative, patient-friendly solutions that enhance the quality of life and offer alternatives to traditional treatments. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AXNX
Country
🇺🇸 United States